Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 22, 2008

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Malignant Ovarian Epithelial TumorOvarian Granulosa Cell TumorOvarian GynandroblastomaOvarian Sertoli-Leydig Cell TumorOvarian Sex Cord Tumor With Annular TubulesOvarian Sex Cord-Stromal TumorOvarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell TypesOvarian Steroid Cell Tumor
Interventions
BIOLOGICAL

Bevacizumab

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (36)

10065

Memorial Sloan-Kettering Cancer Center, New York

19001

Abington Memorial Hospital, Abington

19111

Fox Chase Cancer Center, Philadelphia

27710

Duke University Medical Center, Durham

28203

Carolinas Medical Center/Levine Cancer Institute, Charlotte

30501

Northeast Georgia Medical Center-Gainesville, Gainesville

39216

University of Mississippi Medical Center, Jackson

43210

Ohio State University Comprehensive Cancer Center, Columbus

43214

Riverside Methodist Hospital, Columbus

44060

Lake University Ireland Cancer Center, Mentor

44106

Case Western Reserve University, Cleveland

44109

MetroHealth Medical Center, Cleveland

44111

Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland

44124

Hillcrest Hospital Cancer Center, Mayfield Heights

44195

Cleveland Clinic Foundation, Cleveland

45409

Miami Valley Hospital, Dayton

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

55455

University of Minnesota/Masonic Cancer Center, Minneapolis

60521

Hinsdale Hematology Oncology Associates Incorporated, Hinsdale

Sudarshan K Sharma MD Limted-Gynecologic Oncology, Hinsdale

60611

Northwestern University, Chicago

60637

University of Chicago Comprehensive Cancer Center, Chicago

68114

Nebraska Methodist Hospital, Omaha

73104

University of Oklahoma Health Sciences Center, Oklahoma City

74146

Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa

75235

Parkland Memorial Hospital, Dallas

75390

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

77030

M D Anderson Cancer Center, Houston

80045

University of Colorado Hospital, Aurora

90033

Los Angeles County-USC Medical Center, Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles

06102

Hartford Hospital, Hartford

06050

The Hospital of Central Connecticut, New Britain

02114

Massachusetts General Hospital Cancer Center, Boston

01605

University of Massachusetts Memorial Health Care, Worcester

01655

University of Massachusetts Medical School, Worcester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NRG Oncology

OTHER

lead

National Cancer Institute (NCI)

NIH

NCT00748657 - Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary | Biotech Hunter | Biotech Hunter